Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Egg-Based and Cell-Based Vaccine Platforms on Immune Responses to Repeated Influenza Vaccination
NCT07910266Phase 4Recruiting
- Sponsor
- University of Missouri
- Start
- Oct 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 4 trial of Fluzone Trivalent in influenza, sponsored by University of Missouri. Started Oct 2026; status: recruiting.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07910266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07910266.